{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T02:51:43Z","timestamp":1783047103195,"version":"3.54.6"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.biopha.2015.12.017","type":"journal-article","created":{"date-parts":[[2016,1,8]],"date-time":"2016-01-08T14:53:01Z","timestamp":1452264781000},"page":"23-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Statins inhibited the MIP-1\u03b1 expression via inhibition of Ras\/ERK and Ras\/Akt pathways in myeloma cells"],"prefix":"10.1016","volume":"78","author":[{"given":"Masanobu","family":"Tsubaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Mashimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Kino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arisa","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuki","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiro","family":"Imano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiko","family":"Sakaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Satou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shozo","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2015.12.017_bib0005","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0037-1963(01)90020-4","article-title":"Myeloma bone disease","volume":"38","author":"Callander","year":"2001","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.biopha.2015.12.017_bib0010","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/84209","article-title":"Chemokines and disease","volume":"2","author":"Gerard","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biopha.2015.12.017_bib0015","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1182\/blood.V96.2.671.014k24_671_675","article-title":"Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma","volume":"96","author":"Choi","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2015.12.017_bib0020","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1182\/blood.V97.11.3349","article-title":"Macrophage inflammatory protein-1alpha is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor kappaB ligand","volume":"97","author":"Han","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2015.12.017_bib0025","first-page":"399","article-title":"Macrophage inflammatory protein-1 alpha (LD78) expressed in human bone marrow: its role in regulation of hematopoiesis and osteoclast recruitment","volume":"76","author":"Kukita","year":"1997","journal-title":"Lab. Invest."},{"key":"10.1016\/j.biopha.2015.12.017_bib0030","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11010-007-9485-7","article-title":"Macrophage inflammatory protein-1alpha (MIP-1alpha) enhances a receptor activator of nuclear factor kappaB ligand (RANKL) expression in mouse bone marrow stromal cells and osteoblasts through MAPK and PI3K\/Akt pathways","volume":"304","author":"Tsubaki","year":"2007","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.biopha.2015.12.017_bib0035","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/jcb.22907","article-title":"Macrophage inflammatory protein-1\u03b1 induces osteoclast formation by activation of the MEK\/ERK\/c-Fos pathway and inhibition of the p38MAPK\/IRF-3\/IFN-\u03b2 pathway","volume":"111","author":"Tsubaki","year":"2010","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.biopha.2015.12.017_bib0040","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.leukres.2014.02.010","volume":"38","author":"Wang","year":"2014","journal-title":"Leuk. Res."},{"key":"10.1016\/j.biopha.2015.12.017_bib0045","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1182\/blood.V100.6.2195","article-title":"Role for macrophage inflammatory protein (MIP)-1alpha and MIP-1beta in the development of osteolytic lesions in multiple myeloma","volume":"100","author":"Abe","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2015.12.017_bib0050","doi-asserted-by":"crossref","first-page":"6461","DOI":"10.1158\/0008-5472.CAN-04-0866","article-title":"Blocking the Raf\/MEK\/ERK pathway sensitizes acute myelogenous leukemia cells to lovastatin-induced apoptosis","volume":"64","author":"Wu","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2015.12.017_bib0055","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11010-005-3086-0","article-title":"Mevastatin induces apoptosis in HL60 cells dependently on decrease in phosphorylated ERK","volume":"269","author":"Nishida","year":"2005","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.biopha.2015.12.017_bib0060","first-page":"168","article-title":"Bisphosphonates and statins inhibit expression and secretion of MIP-1\u03b1 via suppression of Ras\/MEK\/ERK\/AML-1A and Ras\/PI3K\/Akt\/AML-1A pathways","volume":"5","author":"Tsubaki","year":"2014","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.biopha.2015.12.017_bib0065","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.cyto.2011.01.005","article-title":"Blockade of the Ras\/MEK\/ERK and Ras\/PI3K\/Akt pathways by statins reduces the expression of bFGF, HGF, and TGF-\u03b2 as angiogenic factors in mouse osteosarcoma","volume":"54","author":"Tsubaki","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.biopha.2015.12.017_bib0070","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1756-9966-29-127","article-title":"Reduction of lung metastasis, cell invasion, and adhesion in mouse melanoma by statin-induced blockade of the Rho\/Rho-associated coiled-coil-containing protein kinase pathway","volume":"29","author":"Kidera","year":"2010","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2015.12.017_bib0075","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1756-9966-30-74","article-title":"Statin-induced apoptosis via the suppression of ERK1\/2 and Akt activation by inhibition of the geranylgeranyl-pyrophosphate biosynthesis in glioblastoma","volume":"30","author":"Yanae","year":"2011","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2015.12.017_bib0080","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.mce.2012.05.002","article-title":"Bisphosphonate- and statin-induced enhancement of OPG expression and inhibition of CD9, M-CSF, and RANKL expressions via inhibition of the Ras\/MEK\/ERK pathway and activation of p38MAPK in mouse bone marrow stromal cell line ST2","volume":"361","author":"Tsubaki","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.biopha.2015.12.017_bib0085","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1600-0765.2006.00911.x","article-title":"High glucose-boosted inflammatory responses to lipopolysaccharide are suppressed by statin","volume":"42","author":"Nareika","year":"2007","journal-title":"J. Periodontal. Res."},{"key":"10.1016\/j.biopha.2015.12.017_bib0090","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/j.1440-1681.2006.04493.x","article-title":"Statins reduce macrophage inflammatory protein-1alpha expression in human activated monocytes","volume":"33","author":"Bruegel","year":"2006","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.biopha.2015.12.017_bib0095","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1349-7006.2007.00651.x","article-title":"Nitrogen-containing bisphosphonate YM529\/ONO-5920, inhibits macrophage inflammatory protein 1 alpha expression and secretion in mouse myeloma cells","volume":"99","author":"Tsubaki","year":"2008","journal-title":"Cancer Sci."},{"key":"10.1016\/j.biopha.2015.12.017_bib0100","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1189\/jlb.72.4.780","article-title":"Role of the autocrine chemokines MIP-1alpha and MIP-1beta in the metastatic behavior of murine T cell lymphoma","volume":"72","author":"Menten","year":"2002","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.biopha.2015.12.017_bib0105","first-page":"121","article-title":"Melatonin inhibits lipopolysaccharide-induced CC chemokine subfamily gene expression in human peripheral blood mononuclear cells in a microarray analysis","volume":"43","author":"Park","year":"2007","journal-title":"J. Periodontal. Res."},{"key":"10.1016\/j.biopha.2015.12.017_bib0110","doi-asserted-by":"crossref","first-page":"5289","DOI":"10.1074\/jbc.271.10.5289","article-title":"Protein prenyltransferases","volume":"271","author":"Casey","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2015.12.017_bib0115","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00018-005-5298-6","article-title":"Isoprenylated proteins","volume":"63","author":"McTaggart","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.biopha.2015.12.017_bib0120","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.atherosclerosis.2005.10.015","article-title":"Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages","volume":"188","author":"Veillard","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.biopha.2015.12.017_bib0125","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2249.2011.04473.x","article-title":"Statin effects on regulatory and proinflammatory factors in chronic idiopathic urticaria","volume":"166","author":"Azor","year":"2011","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.biopha.2015.12.017_bib0130","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nri1391","article-title":"Toll-like receptor signalling","volume":"4","author":"Akira","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2015.12.017_bib0135","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0092-8674(02)00827-9","article-title":"IRAK-M is a negative regulator of Toll-like receptor signaling","volume":"110","author":"Kobayashi","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2015.12.017_bib0140","doi-asserted-by":"crossref","first-page":"36334","DOI":"10.1074\/jbc.M305698200","article-title":"Ras participates in CpG oligodeoxynucleotide signaling through association with toll-like receptor 9 and promotion of interleukin-1 receptor-associated kinase\/tumor necrosis factor receptor-associated factor 6 complex formation in macrophages","volume":"278","author":"Xu","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2015.12.017_bib0145","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1002\/1521-4141(200207)32:7<2037::AID-IMMU2037>3.0.CO;2-I","article-title":"TNFalpha-induced macrophage chemokine secretion is more dependent on NF-kappaB expression than lipopolysaccharides-induced macrophage chemokine secretion","volume":"32","author":"Ciesielski","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.biopha.2015.12.017_bib0150","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.taap.2012.01.024","article-title":"Reduction of metastasis, cell invasion, and adhesion in mouse osteosarcoma by YM529\/ONO-5920-induced blockade of the Ras\/MEK\/ERK and Ras\/PI3K\/Akt pathway","volume":"259","author":"Tsubaki","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.biopha.2015.12.017_bib0155","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.bcp.2012.10.009","article-title":"Nitrogen-containing bisphosphonates induce apoptosis of hematopoietic tumor cells via inhibition of Ras signaling pathways and Bim-mediated activation of the intrinsic apoptotic pathway","volume":"85","author":"Tsubaki","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2015.12.017_bib0160","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1423-0127-21-10","article-title":"Nitrogen-containing bisphosphonates inhibit RANKL-and M-CSF-induced osteoclast formation through the inhibition of ERK1\/2 and Akt activation","volume":"21","author":"Tsubaki","year":"2014","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.biopha.2015.12.017_bib0165","doi-asserted-by":"crossref","first-page":"8648","DOI":"10.1158\/1078-0432.CCR-04-1568","article-title":"3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor, fluvastatin, as a novel agent for prophylaxis of renal cancer metastasis","volume":"10","author":"Horiguchi","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2015.12.017_bib0170","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/hon.869","article-title":"A phase II clinical trial does not show that high dose simvastatin has beneficial effect on markers of bone turnover in multiple myeloma","volume":"27","author":"Sondergaard","year":"2009","journal-title":"Hematol. Oncol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332215301384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332215301384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:59:06Z","timestamp":1760093946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332215301384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":34,"alternative-id":["S0753332215301384"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2015.12.017","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Statins inhibited the MIP-1\u03b1 expression via inhibition of Ras\/ERK and Ras\/Akt pathways in myeloma cells","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2015.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}